Principles and Strengths of In Vitro Testing
In Vitro testing uses cell-based biological models instead of animals or humans.
Eurofins Expands with Acquisition of Nanolab Technologies
Eurofins Scientific, a global scientific leader in bioanalytical testing, announces that it has signed a definitive agreement to acquire Nanolab Technologies, which provides complex knowledge based analytical services to a wide range of high-tech industries. The transaction is Eurofins’ second major acquisition in the rapidly growing materials science and high technology markets, and is a strong follow-up to its purchase of global scientific services company, EAG Laboratories, in December 2017.
Headquartered in the heart of the Silicon Valley, Nanolab Technologies delivers advanced materials and analytical solutions to a $3 billion high technology market comprised of equipment suppliers, original design manufacturers (ODMs) and original equipment manufacturers (OEMs).
The transaction should be immediately margin-accretive for Eurofins after closing. The deal is expected to close in the third quarter of 2018, subject to the fulfilment of regulatory and customary closing conditions.
Comment from John Traub, Nanolab Technologies President and CEO: “There has never been greater demand for smaller, lighter, high-performance products that do more and use less energy. Nanolab Technologies has earned a reputation in North America for delivering the fast, reliable testing and analyses that help drive innovation and quality. As part of Eurofins, we look forward to leveraging those strengths on a global scale.”
Comment from Dr. Gilles Martin, Eurofins CEO: “We are extremely pleased to welcome Nanolab Technologies and its employees to the Eurofins Group, and are enthusiastic about Eurofins’ growing footprint in high-technology sectors. Nanolab Technologies and its materials scientists, engineers and analysts complement the world-class capabilities acquired last year through EAG Laboratories. Its addition to the Eurofins group is testament to our commitment to meet the sophisticated analytical needs of product innovators around the world.”
For more information, please visit www.eurofins.com or contact:
Investor Relations
Eurofins Scientific
Phone: +32 2 766 1620
E-mail: ir@eurofins.com
More content you might like...
Bay Area Biomedical Device Conference
April 3, 2024
EAG Laboratories is proud to sponsor the 2024 Bay Area Biomedical Device Conference.
VCSELs as a Critical Component for the Consumer Electronics 3D Sensing Market
Vertical-cavity surface-emitting lasers, or VCSELs, play a major role in the consumer electronics 3D sensing industry.
ANTEC 2024
March 4-7, 2024
Eurofins EAG Laboratories will be presenting “Characterization of Mycelium Biocomposites Under Simulated Weathering Conditions“ on March 6th. We hope to see you there!